Mobile Contingency Management for Marijuana and Tobacco Cessation

NCT02869451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2020-02-07

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot project is to pilot-test a combined cannabis and smoking cessation treatment. The intervention combines mobile technology with behavioral strategies, counseling, and medications.

Conditions

  • Cigarette Smoking
  • Marijuana Abuse

Interventions

DRUG

bupropion

Prescribed one week prior to quit and continued until the 6 month follow-up visit.

DRUG

transdermal nicotine patch

Initiated at smoking quit date; 7 mg to 21 mg patch depending on amount smoked by participant

DRUG

Nicotine polacrilex

Initiated at smoking quit date.

DRUG

nicotine lozenge

Initiated at smoking quit date.

BEHAVIORAL

counseling for marijuana and smoking cessation

5 sessions of cognitive-behavioral counseling designed to facilitate marijuana and smoking cessation and promote relapse prevention

BEHAVIORAL

mobile contingency management

treatment that provides money rewards for abstinence from smoking and marijuana

Sponsors & Collaborators

Principal Investigators

  • Jean C Beckham, Ph.D. · Study Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-05-17
Completion
2017-05-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869451 on ClinicalTrials.gov